About the role
from listingThe BMT-CT program at Stanford performs autologous and allogeneic transplantations for over 300 patients each year. The program has been very successful with a history of limited morbidity rates and acute mortality that is well below most published reports. In addition to a successful clinical practice, our program researchers are translating their discoveries into new therapies, advancing the efficacy of hematopoietic cell transplantation for patients worldwide.
This is a remote opportunity.
Desired Qualificiations:
Experience with Protocol/IND writing.
Experience with BMT-CT disease focus.
Originally posted on Himalayas